|
CCDC86 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.98130006529618E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16400000036177E-08 |
| Normal-vs-Stage2 |
4.393800E-02 |
| Normal-vs-Stage3 |
2.989200E-04 |
| Normal-vs-Stage4 |
1.695920E-03 |
| Stage1-vs-Stage2 |
4.575000E-01 |
| Stage1-vs-Stage3 |
6.741500E-02 |
| Stage1-vs-Stage4 |
2.534300E-02 |
| Stage2-vs-Stage3 |
7.069900E-02 |
| Stage2-vs-Stage4 |
4.823700E-02 |
| Stage3-vs-Stage4 |
9.196600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.94600002568058E-09 |
| Normal-vs-AfricanAmerican |
1.402500E-04 |
| Normal-vs-Asian |
1.232140E-02 |
| Caucasian-vs-AfricanAmerican |
7.633800E-01 |
| Caucasian-vs-Asian |
4.761900E-02 |
| AfricanAmerican-vs-Asian |
1.867390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24229999620695E-08 |
| Normal-vs-Female |
3.44720000322596E-08 |
| Male-vs-Female |
1.552790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.7406899999961E-05 |
| Normal-vs-Extreme_Weight |
2.78110000029308E-07 |
| Normal-vs-Obese |
3.91000000000696E-05 |
| Normal-vs-Extreme_Obese |
4.213500E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.744000E-01 |
| Normal_Weight-vs-Obese |
9.588200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.661400E-01 |
| Extreme_Weight-vs-Obese |
4.751400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.486000E-01 |
| Obese-vs-Extreme_Obese |
9.117400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.59030000000438E-05 |
| Normal-vs-Age(41-60Yrs) |
2.19200002593567E-09 |
| Normal-vs-Age(61-80Yrs) |
1.01230000004726E-06 |
| Normal-vs-Age(81-100Yrs) |
1.517420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.598540E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.116900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.498610E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.712600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.706100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.377600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.83090000225062E-08 |
| Normal-VS-Type2 PRCC |
2.221300E-04 |
| Normal-VS-KIRP CIMP |
8.361600E-03 |
| Normal-VS-Unclassified PRCC |
3.57149999999917E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.643200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.984000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.127200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.901800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.286600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.213420E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.778990E-04 |
| Normal-vs-N1 |
6.04770000744992E-09 |
| Normal-vs-N2 |
5.859600E-01 |
| N0-vs-N1 |
1.815520E-02 |
| N0-vs-N2 |
4.941400E-01 |
| N1-vs-N2 |
2.967700E-02 |
|
|
